Suppr超能文献

以一种阿育吠陀药物作为辅助因素的运动诱发性过敏反应:一例报告。

Exercise-induced anaphylaxis with an Ayurvedic drug as cofactor: A case report.

作者信息

Losa Francesca, Deidda Margherita, Firinu Davide, Martino Maria Luisa Di, Barca Maria Pina, Giacco Stefano Del

机构信息

Department of Medical Sciences and Public Health and Unit of Allergy and Clinical Immunology, University Hospital "Duilio Casula", University of Cagliari, Monserrato 09042, Italy.

出版信息

World J Clin Cases. 2019 Mar 6;7(5):623-627. doi: 10.12998/wjcc.v7.i5.623.

Abstract

BACKGROUND

The practice of Indian Ayurvedic medicine is spreading in Western countries and Shilajit is one of the most used drugs, for its antioxidant activities and immunomodulatory effects. Albeit Shilajit has showed a high degree of safety, it can act as cofactor of anaphylaxis, especially in condition at high risk, such as mast cell activation syndrome (MCAS). We reported this case to sensitize practitioners to investigate to the use of complementary and alternative medicine, in case of exercise-induced anaphylaxis (EIAn).

CASE SUMMARY

A 43-year-old woman, working as a dance teacher, developed urticaria after ingestion of rice, tuna and Shilajit, which did not respond to intramuscular corticosteroids. Subsequently, she developed dyspnoea and hypotension with loss of consciousness that arose 1 h after sexual activity. The patient did not refer personal history of atopy. Specific IgE for main food allergens resulted negative, with total IgE levels of 14 IU/L. Oral provocation test with Shilajit was not perfomed because the patient refused, but we performed prick-by-prick and patch test that resulted negative. Serum tryptase at the time of anaphylaxis was 20.6 μg/L that fell down to of 10.6 μg/L after therapy, but has remained at the high value after two days and during the follow-up. We performed an analysis of th gene in peripheral blood, which was negative. We felt the diagnosis consistent with EIAn in a patient with a possible MCAS.

CONCLUSION

In Western countries the use of drugs from Ayurvedic medicine is more common than in the past. These substances can be cofactors of anaphylaxis in patients with risk factors.

摘要

背景

印度阿育吠陀医学在西方国家日益普及,希拉季特因具有抗氧化活性和免疫调节作用,成为最常用的药物之一。尽管希拉季特已显示出高度安全性,但它可能作为过敏反应的辅助因素,尤其是在高风险情况下,如肥大细胞活化综合征(MCAS)。我们报告此病例,以提高从业者对运动诱发过敏反应(EIAn)时使用补充和替代医学进行调查的意识。

病例摘要

一名43岁的舞蹈教师,在摄入大米、金枪鱼和希拉季特后出现荨麻疹,肌肉注射皮质类固醇治疗无效。随后,她在性行为1小时后出现呼吸困难、低血压并失去意识。患者否认有特应性个人史。主要食物过敏原的特异性IgE结果为阴性,总IgE水平为14 IU/L。由于患者拒绝,未进行希拉季特口服激发试验,但我们进行了点刺试验和斑贴试验,结果均为阴性。过敏反应发生时血清类胰蛋白酶水平为20.6μg/L,治疗后降至10.6μg/L,但两天后及随访期间仍保持在较高水平。我们对外周血中的基因进行了分析,结果为阴性。我们认为该诊断符合一名可能患有MCAS患者的EIAn。

结论

在西方国家,阿育吠陀医学药物的使用比过去更为普遍。这些物质可能是有危险因素患者过敏反应的辅助因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5dc/6406205/1761f2962054/WJCC-7-623-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验